Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2020/056966external-prioritypatent/WO2021019386A1/en
Application filed by Janssen Biotech IncfiledCriticalJanssen Biotech Inc
Publication of DOP2022000014ApublicationCriticalpatent/DOP2022000014A/es
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
La presente descripción proporciona receptores de antígenos quiméricos (CAR) que se dirigen específicamente a la calicreína humana 2 (hK2), y células inmunosensibles que comprenden tales CAR, para el tratamiento del cáncer.
DO2022000014A2019-07-262022-01-20Receptor de antígeno quimérico (car) anti-hk2
DOP2022000014A
(es)